Glimy M V2 Tablet SR
Glimy M V2 Tablet SR
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Ozomet-VG2 Tablet SR
Ozone Pharmaceuticals Ltd
Voglibose 0.2mg
Pack Size
1 units
Price
Save ₹96
that's 69% off!
About This Medicine
Product description & overview
Glimy M V2 Tablet SR: A Comprehensive Treatment Solution
Glimy M V2 Tablet SR is a once-daily combination tablet designed to manage blood sugar levels in adults with type 2 diabetes. This formulation combines the proven efficacy of three key ingredients:
* Glimepiride (2mg): A sulfonylurea medication that stimulates insulin secretion from beta cells, ultimately lowering blood glucose levels.
* Metformin (500mg): A first-line treatment for type 2 diabetes, metformin reduces hepatic glucose production and improves insulin sensitivity, leading to effective blood sugar control.
* Voglibose (0.2mg): This alpha-glucosidase inhibitor slows down the digestion of carbohydrates, preventing rapid absorption into the bloodstream and minimizing postprandial hyperglycemia.
The combined action of these three ingredients ensures comprehensive blood sugar management for optimal control. Glimy M V2 Tablet SR is designed for easy administration and provides convenience through a single daily dosage.
Disclaimer: This description should not be interpreted as medical advice. Consult with your healthcare provider before starting any new medication or making changes to your current treatment plan.
Active composition
Glimepiride 2 mg
+2 more active ingredients
About Glimepiride
Glimepiride is an oral hypoglycemic agent used to manage blood sugar levels in patients with type 2 diabetes mellitus. It works by stimulating the pancreas to release more insulin, thereby lowering blood glucose levels and preventing the symptoms associated with diabetes. Glimepiride is often prescribed alongside diet and exercise to enhance glycemic control and reduce the risk of diabetes-related complications, such as kidney damage and neuropathy. In summary, Glimepiride is an essential medication for controlling blood sugar levels in type 2 diabetes patients.
How It Works
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
All Active Ingredients
Voglibose
Voglibose inhibits intestinal alpha-glucosidases, delaying carbohydrate digestion and absorption, thus lowering postprandial glucose levels.
Metformin
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
It is unsafe to consume alcohol with Glimy M V2 Tablet SR.
High Risk
Pregnancy
Glimy M V2 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Driving
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Liver
Glimy M V2 Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Glimy M V2 Tablet SR may be needed. Please consult your doctor. Glimy M V2 Tablet SR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Regular Checkup
Breastfeeding
Glimy M V2 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Consult Doctor
Kidney
Glimy M V2 Tablet SR is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor. Use of Glimy M V2 Tablet SR is, however, not recommended in patients with severe kidney disease.
Regular Checkup
Customer Reviews
0 reviews for Glimy M V2 Tablet SR
Products matching your search
Cilnikem-OM Tablet
Cilnikem-OM Tablet
Glimser Forte 1 Tablet PR
Glimser Forte 1 Tablet PR
Esmodoz-RD Capsule
Esmodoz-RD Capsule
Emeerab 20mg Tablet
Emeerab 20mg Tablet
Gabarich 150mg/750mcg Tablet
Gabarich 150mg/750mcg Tablet
Goldtam-D Tablet SR
Goldtam-D Tablet SR
Glimp M 2 SR Tablet
Glimp M 2 SR Tablet
Goldspas Tablet